CRO

News

Evotec slashes staff as turnaround plan gathers pace

Evotec has announced the next phase of its company overhaul, dubbed Horizon, that will see 800 people lose their jobs in a bid to cut €75m in costs.

Patients

From insight to impact: Why the patient voice will redefine ...

Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?

R&D

Bringing therapies to patients quicker with integrated CDMO ...

Biotechs and pharmaceutical companies can receive enormous value from a trusted partnership with an integrated CDMO and CRO.

Sales & Marketing

Solution Spotlight: Accelerator Drug Development

Thermo Fisher Scientific’s Accelerator Drug Development is a suite of integrated services combining CDMO and CRO to streamline drug development.

News

Halozyme abandons its €2bn pursuit of Evotec

Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been unwilling to engage with negotiations

News

AZ launches digital clinical trials business

AstraZeneca has launched a separate business unit that will take what the drugmaker has learned from running digitally-powered clinical trials and offer that experience to

Evotec slashes staff as turnaround plan gathers pace

From insight to impact: Why the patient voice will redefine ...

Bringing therapies to patients quicker with integrated CDMO ...

Solution Spotlight: Accelerator Drug Development

Halozyme abandons its €2bn pursuit of Evotec

AZ launches digital clinical trials business

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

CRO

Editor's Picks